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Few inventions of biotechnology have been as
commercially successful, scientifically contested and
publicly debated as glyphosate-tolerant transgenic soy in
industrial agriculture. During the past decade our research
group—which is based in Norway but which has
international colleagues and collaborators worldwide—
has conducted numerous studies and risk assessments of
transgenic crop varieties, notably to understand the potential
combinatorial effects of crop–herbicide interplay. Focusing
on glyphosate-tolerant soy, we have found that this crop is
substantially different from conventional non-GMO1
soybean, not least regarding composition of nutrients
and residual content of glyphosate, which is surprisingly
high [1]. Our research has concluded that one main
reason that previous studies into the same subject have
not found such differences between transgenic soybean
and unmodified varieties has been the fact that numerous
previous studies are methodologically flawed [2].
Our review of 30 studies in which glyphosate-tolerant
transgenic crops (soy, maize, canola) were assessed in
comparison with unmodified varieties showed that most
such studies were conducted with material produced
under unrepresentative, artificial circumstances: notably,
the glyphosate-tolerant crops were grown without the
complementary herbicide (14 out of 30 studies). Reviewing
the studies that did employ the herbicide, we saw that
(a) it was difficult to ascertain whether the dosage was
representative of real-life applications, and (b) the crops
thus produced were not analysed for herbicide residues.
These flawed studies were predominantly funded by
industry, whereas the “independent studies” conducted by
researchers from universities and without conflicting
interests were found to have been conducted methodologi-
cally more correctly. These studies overwhelmingly (8 out
of 9) showed significant differences [2]. Our retrospective
view urges us to recommend research to investigate
whether these negative effects of GMO are correlated
with high levels of herbicide residue in those crops [7].
In a further series of tests, we conducted ecotoxico-
logical and animal feeding studies in model aquatic
environments. These studies showed that glyphosate
itself was up to 300 times more toxic to the test animal
(D. magna) than claimed in similar studies that had been
conducted (by industry) three decades previously [3].
Our feeding studies showed that animals fed glyphosate-
tolerant soy performed worse (growth, reproduction)
than animals fed non-GMO soybean [4]. A further series
of feeding studies with eight independent diets made
from separate harvests of transgenic soybean (with levels
of glyphosate residues ranging from 1.1 to 15.1 ppm)
showed a consistently significant correlation linking
higher glyphosate levels in the soy feed to stunted growth,
delayed reproduction and reduced fecundity [5].
We also reviewed 20 industry studies from the 1970s
and 1980s that investigated the ecotoxicology of
glyphosate [6]. We found the research reports to be
partly flawed; e.g., with hand-written changes that
altered the conclusions, downplayed indications, or
exaggerated regulatory importance by placing too strong
interpretative weight on weak industry studies, thereby
inflated to become core evidence of low toxicity. Our
documentation was obtained through FOIA and indicates
that the US EPA contributed to such skewing of evidence,
assisting industry and establishing the non-toxicity of
glyphosate as a regulatory fact [6].2
In a third review [7], we collected available evidence
on glyphosate effects in non-target organisms and
concluded that one of the main challenges with this
chemical at present is that it is used indiscriminately, in
high volumes and in diverse types of applications/crop
systems. In addition, the use of glyphosate as a
preharvest desiccant in agriculture places an unnecessary
additional burden on consumers, as is evident from our
findings of high levels of residues in crops such as lentils
(i.e., 14 ppm [7]). Thus, through a decade of analysis,
numerous animal studies, archive studies and literature
reviews we have amassed considerable evidence, which
has been published (refs 1–7).
Throughout our work we have promulgated a series
of open questions, and have expected industry scientists
to respond to our findings, which are so obviously
different from those presented by industry. In particular,
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we expected a storm of arguments and strong attempts at
rebuttal of our assertions that several industry studies are
actually flawed, some even to such an extent that
specific publications should be retracted and disregarded
as evidence. Although we are impartial and disinterested
regarding the commercial interests involved, it has not
escaped our attention that transgenic crops as well as the
complementary herbicide glyphosate have both been
inventions of the Monsanto Company.
Our main objection towards that company relates to
the fact that they have not responded to our letters, e-mails
or telephone calls; they have not been willing to share
information, have not been willing to let us have access to
their patented transgenic material and have not commented
upon any of our findings nor answered any of our
questions. Other independent researchers have noted the
fact that the glyphosate-tolerant crops, the so-called
“Roundup Ready” biotechnological package, have been
commercially hugely successful and a source of large
revenues for the patent holder. However, following
concerted criticism and new research findings on,
primarily, the toxicity of the herbicide, the World Health
Organization (WHO), the European Food Safety
Authority (EFSA) and other acknowledged regulatory
authorities have embarked on initiatives to thoroughly
reëvaluate the toxicity of glyphosate, notably accentuated
by the claims of potential carcinogenicity. We note that
the producer, Monsanto, has not expended any visible effort
on responding, either officially or academically, to the
wave of new research findings on glyphosate and
Roundup. The new findings thus stand unopposed,
despite being in stark contrast to former findings
presented by industry. Our concern is not lessened by the
fact that on previous occasions when independent
researchers presented findings that were unfavorable
towards biotechnological inventions (e.g., specific GMOs)
and voiced consternation, concerted efforts were made to
swiftly discredit them in “witch-hunts” (e.g., the cases of
the individual researchers Emma Rosi-Marshall [8],
Árpád Pusztai, [9] Ignacio Chapela and, notably, the
cynical ridicule inflicted on Irina Ermakova by the editors
of the journal Nature Biotechnology in 2007 [10]). It has
been inferred that these often brutal “reprisals” were
orchestrated by industry scientists coöperating with the
editors of certain scientific journals, editors who are
supportive of such biotechnological products or are even
perceived as having conflicts of interests [11, 12]. It has
also been averred that for decades there has been a
strong discrepancy in the manner that results which
found unfavorable effects of transgenic products were
received, when compared to studies that found no
substantial differences between transgenic produce and
unmodified controls [13].
Thus, we had expected that our findings would be
carefully scrutinized by the researchers whom we had
criticized and we had braced ourselves to stand upright in
expectation of the habitual vexatious storm of
harassment from the biotech industry and its allies. But
no such thing happened: instead the Monsanto
shareholders sold the company, numerous countries
banned GMO crops and US President Obama signed
legislation that effectively means that food from
GMOs—such as the glyphosate-tolerant soybean—will
be labeled and consumers will finally be informed about
the contents of the produce on supermarket shelves.
Numerous recent publications present indications and
scientific conclusions in line with our findings: that
glyphosate, Roundup and Roundup Ready crops present
significantly higher risks than previously acknowledged.
By and large, these recent scientific results stand
unrefuted and uncommented upon by the industry making
the products. Thus, it seems that industry has locked its
doors and turned off the lights, possibly waiting for the
turmoil to subside and business to return to normal.
However, researchers from independent scientific
communities as well as professionals of regulatory
agencies are still waiting for responses, with numerous
questions unanswered.
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